

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 9.09004828 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 8.81881696 |
| 3 | white fat cell differentiation (GO:0050872) | 8.11869021 |
| 4 | triglyceride catabolic process (GO:0019433) | 7.86969760 |
| 5 | valine metabolic process (GO:0006573) | 7.66450180 |
| 6 | brown fat cell differentiation (GO:0050873) | 7.64375435 |
| 7 | biotin metabolic process (GO:0006768) | 7.38792306 |
| 8 | neutral lipid catabolic process (GO:0046461) | 7.06462486 |
| 9 | acylglycerol catabolic process (GO:0046464) | 7.06462486 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 6.08401058 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 6.06044767 |
| 12 | triglyceride biosynthetic process (GO:0019432) | 6.00724293 |
| 13 | lipid particle organization (GO:0034389) | 5.87028709 |
| 14 | acylglycerol biosynthetic process (GO:0046463) | 5.76416301 |
| 15 | neutral lipid biosynthetic process (GO:0046460) | 5.76416301 |
| 16 | carnitine shuttle (GO:0006853) | 5.76060124 |
| 17 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.50740800 |
| 18 | positive regulation of fatty acid oxidation (GO:0046321) | 5.40177179 |
| 19 | regulation of cholesterol storage (GO:0010885) | 5.35206027 |
| 20 | glycerolipid catabolic process (GO:0046503) | 5.29808424 |
| 21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.25635697 |
| 22 | branched-chain amino acid metabolic process (GO:0009081) | 5.20112147 |
| 23 | branched-chain amino acid catabolic process (GO:0009083) | 5.15502921 |
| 24 | fatty acid beta-oxidation (GO:0006635) | 5.13907281 |
| 25 | lipid storage (GO:0019915) | 5.05495308 |
| 26 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.03130908 |
| 27 | thioester biosynthetic process (GO:0035384) | 4.93834044 |
| 28 | acyl-CoA biosynthetic process (GO:0071616) | 4.93834044 |
| 29 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.84652699 |
| 30 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.84100084 |
| 31 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.83804176 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.81912626 |
| 33 | regulation of platelet aggregation (GO:0090330) | 4.72213530 |
| 34 | carnitine transmembrane transport (GO:1902603) | 4.62711532 |
| 35 | coenzyme A biosynthetic process (GO:0015937) | 4.55493083 |
| 36 | triglyceride metabolic process (GO:0006641) | 4.54771266 |
| 37 | response to dietary excess (GO:0002021) | 4.54717015 |
| 38 | fatty acid oxidation (GO:0019395) | 4.50030132 |
| 39 | lipid oxidation (GO:0034440) | 4.40789432 |
| 40 | fatty acid catabolic process (GO:0009062) | 4.40578525 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.31229283 |
| 42 | acylglycerol metabolic process (GO:0006639) | 4.30468891 |
| 43 | neutral lipid metabolic process (GO:0006638) | 4.24291038 |
| 44 | regulation of fatty acid oxidation (GO:0046320) | 4.20830337 |
| 45 | amino-acid betaine transport (GO:0015838) | 4.20719196 |
| 46 | carnitine transport (GO:0015879) | 4.20719196 |
| 47 | thrombin receptor signaling pathway (GO:0070493) | 4.20308953 |
| 48 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.18726264 |
| 49 | regulation of platelet activation (GO:0010543) | 4.18560678 |
| 50 | adenosine receptor signaling pathway (GO:0001973) | 4.10242880 |
| 51 | fatty acid homeostasis (GO:0055089) | 4.08495417 |
| 52 | angiogenesis involved in wound healing (GO:0060055) | 4.03812024 |
| 53 | tricarboxylic acid metabolic process (GO:0072350) | 4.01931585 |
| 54 | negative regulation of protein autophosphorylation (GO:0031953) | 4.01710892 |
| 55 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.01502306 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 3.95429860 |
| 57 | negative regulation of lipid storage (GO:0010888) | 3.93507376 |
| 58 | lipoxygenase pathway (GO:0019372) | 3.92699586 |
| 59 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.92208772 |
| 60 | pentose-phosphate shunt (GO:0006098) | 3.90986538 |
| 61 | protein neddylation (GO:0045116) | 3.90367337 |
| 62 | phospholipid homeostasis (GO:0055091) | 3.90101162 |
| 63 | cellular response to lithium ion (GO:0071285) | 3.87896100 |
| 64 | NADH metabolic process (GO:0006734) | 3.87663429 |
| 65 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.87539806 |
| 66 | alpha-linolenic acid metabolic process (GO:0036109) | 3.87322278 |
| 67 | NADPH regeneration (GO:0006740) | 3.86779992 |
| 68 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.85677823 |
| 69 | transcytosis (GO:0045056) | 3.85421767 |
| 70 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.80751937 |
| 71 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.80055925 |
| 72 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.79765963 |
| 73 | neutrophil activation (GO:0042119) | 3.78952941 |
| 74 | positive regulation of glomerulus development (GO:0090193) | 3.78147619 |
| 75 | protein heterotrimerization (GO:0070208) | 3.75497463 |
| 76 | coenzyme A metabolic process (GO:0015936) | 3.74015158 |
| 77 | negative regulation of granulocyte differentiation (GO:0030853) | 3.71923790 |
| 78 | intracellular lipid transport (GO:0032365) | 3.71386629 |
| 79 | positive regulation of glucose import (GO:0046326) | 3.67345330 |
| 80 | glycerol metabolic process (GO:0006071) | 3.66818033 |
| 81 | positive regulation of lipid catabolic process (GO:0050996) | 3.64423560 |
| 82 | negative regulation of platelet activation (GO:0010544) | 3.64392725 |
| 83 | negative regulation of norepinephrine secretion (GO:0010700) | 3.61825101 |
| 84 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.61361421 |
| 85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.60132724 |
| 86 | regulation of cholesterol efflux (GO:0010874) | 3.58617660 |
| 87 | platelet aggregation (GO:0070527) | 3.58386495 |
| 88 | positive regulation of lipid storage (GO:0010884) | 3.54649355 |
| 89 | diacylglycerol metabolic process (GO:0046339) | 3.54530307 |
| 90 | growth hormone receptor signaling pathway (GO:0060396) | 3.53288719 |
| 91 | L-serine transport (GO:0015825) | 3.47192445 |
| 92 | negative regulation of phagocytosis (GO:0050765) | 3.46124569 |
| 93 | plasma lipoprotein particle clearance (GO:0034381) | 3.44993125 |
| 94 | oxaloacetate metabolic process (GO:0006107) | 3.43070657 |
| 95 | long-chain fatty acid transport (GO:0015909) | 3.41316113 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.40987696 |
| 97 | negative regulation of metanephros development (GO:0072217) | 3.40275176 |
| 98 | negative regulation of macrophage differentiation (GO:0045650) | 3.38934331 |
| 99 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.38794903 |
| 100 | cellular response to epinephrine stimulus (GO:0071872) | 3.38484379 |
| 101 | positive regulation of mast cell activation (GO:0033005) | 3.36695950 |
| 102 | tricarboxylic acid cycle (GO:0006099) | 3.35207638 |
| 103 | positive regulation of cholesterol efflux (GO:0010875) | 3.34421233 |
| 104 | ovulation from ovarian follicle (GO:0001542) | 3.34392073 |
| 105 | negative regulation of response to food (GO:0032096) | 3.32925926 |
| 106 | negative regulation of appetite (GO:0032099) | 3.32925926 |
| 107 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.32274627 |
| 108 | granulocyte activation (GO:0036230) | 3.30623379 |
| 109 | negative regulation of T cell apoptotic process (GO:0070233) | 3.29778268 |
| 110 | regulation of lipoprotein metabolic process (GO:0050746) | 3.28742803 |
| 111 | adaptation of signaling pathway (GO:0023058) | 3.28706518 |
| 112 | monocarboxylic acid catabolic process (GO:0072329) | 3.28601437 |
| 113 | phosphatidic acid metabolic process (GO:0046473) | 3.28163008 |
| 114 | phosphatidic acid biosynthetic process (GO:0006654) | 3.28163008 |
| 115 | fat cell differentiation (GO:0045444) | 3.27645341 |
| 116 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.27446687 |
| 117 | regulation of lipid storage (GO:0010883) | 3.26119291 |
| 118 | positive regulation of sterol transport (GO:0032373) | 3.25931936 |
| 119 | positive regulation of cholesterol transport (GO:0032376) | 3.25931936 |
| 120 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25311644 |
| 121 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.23980073 |
| 122 | negative regulation of gluconeogenesis (GO:0045721) | 3.23616343 |
| 123 | cellular lipid catabolic process (GO:0044242) | 3.23211420 |
| 124 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.22690994 |
| 125 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.22172359 |
| 126 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.22172359 |
| 127 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.22172359 |
| 128 | regulation of triglyceride catabolic process (GO:0010896) | 3.16223433 |
| 129 | extracellular fibril organization (GO:0043206) | 3.15939737 |
| 130 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.14608160 |
| 131 | low-density lipoprotein particle remodeling (GO:0034374) | 3.13313014 |
| 132 | positive regulation of receptor recycling (GO:0001921) | 3.12994071 |
| 133 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12917476 |
| 134 | linoleic acid metabolic process (GO:0043651) | 3.11659254 |
| 135 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.05178203 |
| 136 | fibril organization (GO:0097435) | 2.94271925 |
| 137 | negative regulation of stress fiber assembly (GO:0051497) | 2.92738578 |
| 138 | megakaryocyte development (GO:0035855) | 2.92469866 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91694615 |
| 140 | autophagic vacuole fusion (GO:0000046) | 2.87430450 |
| 141 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85902631 |
| 142 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.85852261 |
| 143 | leukocyte degranulation (GO:0043299) | 2.85067222 |
| 144 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.84935299 |
| 145 | regulation of mast cell degranulation (GO:0043304) | 2.83334281 |
| 146 | cellular extravasation (GO:0045123) | 2.80911159 |
| 147 | response to hydroperoxide (GO:0033194) | 2.79725799 |
| 148 | platelet degranulation (GO:0002576) | 2.79598061 |
| 149 | endothelium development (GO:0003158) | 2.76492124 |
| 150 | response to epinephrine (GO:0071871) | 2.76473492 |
| 151 | fatty acid elongation (GO:0030497) | 2.73051086 |
| 152 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.72962876 |
| 153 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.70998014 |
| 154 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.69851195 |
| 155 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.69813254 |
| 156 | platelet activation (GO:0030168) | 2.69286604 |
| 157 | phagocytosis, recognition (GO:0006910) | 2.67729949 |
| 158 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.66552898 |
| 159 | regulation of sterol transport (GO:0032371) | 2.66531206 |
| 160 | regulation of cholesterol transport (GO:0032374) | 2.66531206 |
| 161 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.66141634 |
| 162 | purinergic receptor signaling pathway (GO:0035587) | 2.65187677 |
| 163 | triglyceride homeostasis (GO:0070328) | 2.64473077 |
| 164 | acylglycerol homeostasis (GO:0055090) | 2.64473077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.46684252 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.46375462 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.13128830 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.83634855 |
| 5 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.69504376 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.56682627 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.43396921 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80078559 |
| 9 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.70078474 |
| 10 | GATA1_19941826_ChIP-Seq_K562_Human | 2.58271365 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54816626 |
| 12 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.53045390 |
| 13 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.51068921 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50591685 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.42118610 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.40804013 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 2.36574267 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31957167 |
| 19 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.30107492 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.25290460 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.23989792 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22936259 |
| 23 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.22537565 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22256065 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21909113 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.20446361 |
| 27 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.19883238 |
| 28 | GATA2_19941826_ChIP-Seq_K562_Human | 2.18140918 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12375900 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.12164901 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07661016 |
| 32 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.06419429 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06189617 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02810789 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02678278 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.1495745 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.98989350 |
| 38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86245952 |
| 39 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82740910 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82003358 |
| 41 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75291606 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74478010 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.71739619 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70401242 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.67144242 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64323112 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.62671071 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.61355906 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.59625005 |
| 50 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.53766738 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49471751 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46985368 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46070619 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44439460 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40379243 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39556172 |
| 57 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.39399139 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37426154 |
| 59 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.33965772 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33727446 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31590103 |
| 62 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30739432 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30451353 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29652503 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28048642 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27363298 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26159630 |
| 68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25718624 |
| 69 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25718624 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22383103 |
| 71 | MYB_26560356_Chip-Seq_TH2_Human | 1.19600631 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19479301 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18959691 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18440841 |
| 75 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18274501 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18211464 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 1.17166448 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16550679 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15779608 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14809850 |
| 81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14465705 |
| 82 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.14324490 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14019796 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13563887 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11995210 |
| 86 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11117676 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11013295 |
| 88 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10832857 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10471864 |
| 90 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10239282 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09962768 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 1.09422542 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08222956 |
| 94 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.07932659 |
| 95 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07899807 |
| 96 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07515973 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07495425 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05864462 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04612174 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04441927 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02011286 |
| 102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00840633 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00593857 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00535215 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00519056 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99011334 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98833369 |
| 108 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97401438 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96699564 |
| 110 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95764742 |
| 111 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95301072 |
| 112 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95163486 |
| 113 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95091523 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94552581 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94515997 |
| 116 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94228499 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94053327 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92849936 |
| 119 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.92255868 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92032509 |
| 121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91894966 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90795807 |
| 123 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90333566 |
| 124 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90207799 |
| 125 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.89964434 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89596412 |
| 127 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89007241 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86895831 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85765843 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85561443 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84996608 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84996608 |
| 133 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83255322 |
| 134 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82676043 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82199797 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81244672 |
| 137 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78860558 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78376683 |
| 139 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77210746 |
| 140 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75986242 |
| 141 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74156094 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74097307 |
| 143 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73691660 |
| 144 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73277624 |
| 145 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72957574 |
| 146 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70563962 |
| 147 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.70537780 |
| 148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70160630 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68309187 |
| 150 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.66299518 |
| 151 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.63430782 |
| 152 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.63222045 |
| 153 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.62726268 |
| 154 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62149460 |
| 155 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.61717661 |
| 156 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61265747 |
| 157 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.60716877 |
| 158 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.60110827 |
| 159 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.59991224 |
| 160 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.57833144 |
| 161 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57248712 |
| 162 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.56950795 |
| 163 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56394621 |
| 164 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56204262 |
| 165 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.55840332 |
| 166 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.55840332 |
| 167 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.55738206 |
| 168 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.54997412 |
| 169 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.54728201 |
| 170 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.54728201 |
| 171 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.54686138 |
| 172 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53774768 |
| 173 | AR_25329375_ChIP-Seq_VCAP_Human | 0.53606293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.54613559 |
| 2 | MP0005464_abnormal_platelet_physiology | 5.71767412 |
| 3 | MP0005666_abnormal_adipose_tissue | 5.61290497 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 5.09618406 |
| 5 | MP0004130_abnormal_muscle_cell | 4.88864474 |
| 6 | MP0005375_adipose_tissue_phenotype | 4.14765684 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 3.77341572 |
| 8 | MP0000013_abnormal_adipose_tissue | 3.47076617 |
| 9 | MP0002971_abnormal_brown_adipose | 3.27826249 |
| 10 | MP0002876_abnormal_thyroid_physiology | 3.23557982 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.16286077 |
| 12 | MP0000003_abnormal_adipose_tissue | 2.96361567 |
| 13 | MP0005275_abnormal_skin_tensile | 2.73431342 |
| 14 | MP0009115_abnormal_fat_cell | 2.69801275 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.66223142 |
| 16 | MP0005334_abnormal_fat_pad | 2.61939076 |
| 17 | MP0003303_peritoneal_inflammation | 2.44546253 |
| 18 | MP0002970_abnormal_white_adipose | 2.29157742 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.11243985 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.10811226 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.10702576 |
| 22 | MP0003959_abnormal_lean_body | 2.08990782 |
| 23 | MP0005535_abnormal_body_temperature | 2.07427006 |
| 24 | MP0001661_extended_life_span | 1.94821951 |
| 25 | MP0003011_delayed_dark_adaptation | 1.94340102 |
| 26 | MP0003436_decreased_susceptibility_to | 1.92750303 |
| 27 | MP0005365_abnormal_bile_salt | 1.92746927 |
| 28 | MP0005083_abnormal_biliary_tract | 1.81338702 |
| 29 | MP0001881_abnormal_mammary_gland | 1.79458222 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.77416258 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.77416258 |
| 32 | MP0005448_abnormal_energy_balance | 1.77196276 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.72291416 |
| 34 | MP0004272_abnormal_basement_membrane | 1.63980232 |
| 35 | MP0002078_abnormal_glucose_homeostasis | 1.59952856 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.57593702 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.54969302 |
| 38 | MP0003724_increased_susceptibility_to | 1.54538826 |
| 39 | MP0005452_abnormal_adipose_tissue | 1.54531735 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.54178549 |
| 41 | MP0003186_abnormal_redox_activity | 1.52122664 |
| 42 | MP0002419_abnormal_innate_immunity | 1.51010802 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 1.45985593 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.43947928 |
| 45 | MP0001851_eye_inflammation | 1.40159203 |
| 46 | MP0002796_impaired_skin_barrier | 1.38390579 |
| 47 | MP0002254_reproductive_system_inflammat | 1.34840344 |
| 48 | MP0002132_abnormal_respiratory_system | 1.34050475 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.33414966 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.30031758 |
| 51 | MP0000858_altered_metastatic_potential | 1.28348430 |
| 52 | MP0002060_abnormal_skin_morphology | 1.28054436 |
| 53 | MP0000249_abnormal_blood_vessel | 1.27875770 |
| 54 | MP0000609_abnormal_liver_physiology | 1.25884522 |
| 55 | MP0005671_abnormal_response_to | 1.24036132 |
| 56 | MP0005025_abnormal_response_to | 1.22473471 |
| 57 | MP0004510_myositis | 1.20684113 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.13432714 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.13419644 |
| 60 | MP0002723_abnormal_immune_serum | 1.12038446 |
| 61 | MP0003828_pulmonary_edema | 1.11278420 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.10766599 |
| 63 | MP0002398_abnormal_bone_marrow | 1.10276234 |
| 64 | MP0001819_abnormal_immune_cell | 1.08642098 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.08376368 |
| 66 | MP0006138_congestive_heart_failure | 1.06541338 |
| 67 | MP0001800_abnormal_humoral_immune | 1.06167039 |
| 68 | MP0003690_abnormal_glial_cell | 1.04415799 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.04214097 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.03463651 |
| 71 | MP0003075_altered_response_to | 1.02543572 |
| 72 | MP0009785_altered_susceptibility_to | 1.01526625 |
| 73 | MP0003953_abnormal_hormone_level | 0.99199859 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.98688129 |
| 75 | MP0004084_abnormal_cardiac_muscle | 0.98371169 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.96182081 |
| 77 | MP0005647_abnormal_sex_gland | 0.95946873 |
| 78 | MP0002139_abnormal_hepatobiliary_system | 0.95882039 |
| 79 | MP0003045_fibrosis | 0.95762089 |
| 80 | MP0004947_skin_inflammation | 0.95538939 |
| 81 | MP0002638_abnormal_pupillary_reflex | 0.93739695 |
| 82 | MP0001666_abnormal_nutrient_absorption | 0.93674033 |
| 83 | MP0000685_abnormal_immune_system | 0.93423910 |
| 84 | MP0006036_abnormal_mitochondrial_physio | 0.93167877 |
| 85 | MP0008775_abnormal_heart_ventricle | 0.92849480 |
| 86 | MP0005387_immune_system_phenotype | 0.92742273 |
| 87 | MP0001790_abnormal_immune_system | 0.92742273 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.92660695 |
| 89 | MP0004883_abnormal_blood_vessel | 0.91348399 |
| 90 | MP0001663_abnormal_digestive_system | 0.90064510 |
| 91 | MP0008260_abnormal_autophagy | 0.89959460 |
| 92 | MP0001845_abnormal_inflammatory_respons | 0.88259507 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.88006631 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.83544407 |
| 95 | MP0009764_decreased_sensitivity_to | 0.83070213 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.83039252 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.82137177 |
| 98 | MP0002722_abnormal_immune_system | 0.81978818 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.81542775 |
| 100 | MP0001756_abnormal_urination | 0.81086765 |
| 101 | MP0002429_abnormal_blood_cell | 0.78939108 |
| 102 | MP0003646_muscle_fatigue | 0.78633067 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.78551718 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.78398180 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.78276842 |
| 106 | MP0000716_abnormal_immune_system | 0.78058115 |
| 107 | MP0001764_abnormal_homeostasis | 0.77893308 |
| 108 | MP0003948_abnormal_gas_homeostasis | 0.75686628 |
| 109 | MP0003879_abnormal_hair_cell | 0.75331279 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.75304759 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75097297 |
| 112 | MP0009278_abnormal_bone_marrow | 0.75094603 |
| 113 | MP0002166_altered_tumor_susceptibility | 0.73976635 |
| 114 | MP0003866_abnormal_defecation | 0.73282844 |
| 115 | MP0008872_abnormal_physiological_respon | 0.73245996 |
| 116 | MP0002405_respiratory_system_inflammati | 0.71937576 |
| 117 | MP0005620_abnormal_muscle_contractility | 0.71418125 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.70685538 |
| 119 | MP0001544_abnormal_cardiovascular_syste | 0.70150133 |
| 120 | MP0005385_cardiovascular_system_phenoty | 0.70150133 |
| 121 | MP0000343_altered_response_to | 0.69078463 |
| 122 | MP0005164_abnormal_response_to | 0.68876708 |
| 123 | MP0008874_decreased_physiological_sensi | 0.68663461 |
| 124 | MP0003950_abnormal_plasma_membrane | 0.68392603 |
| 125 | MP0003868_abnormal_feces_composition | 0.67942913 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.67881109 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.67239016 |
| 128 | MP0010234_abnormal_vibrissa_follicle | 0.67136576 |
| 129 | MP0005390_skeleton_phenotype | 0.65646518 |
| 130 | MP0000750_abnormal_muscle_regeneration | 0.64635893 |
| 131 | MP0002168_other_aberrant_phenotype | 0.61765141 |
| 132 | MP0005332_abnormal_amino_acid | 0.60778831 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.59807733 |
| 134 | MP0002006_tumorigenesis | 0.59677069 |
| 135 | MP0004147_increased_porphyrin_level | 0.58716492 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.58513278 |
| 137 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57940616 |
| 138 | MP0004087_abnormal_muscle_fiber | 0.56440020 |
| 139 | MP0004782_abnormal_surfactant_physiolog | 0.55486228 |
| 140 | MP0002295_abnormal_pulmonary_circulatio | 0.54763033 |
| 141 | MP0005220_abnormal_exocrine_pancreas | 0.53937695 |
| 142 | MP0002009_preneoplasia | 0.53801814 |
| 143 | MP0001879_abnormal_lymphatic_vessel | 0.53740734 |
| 144 | MP0009672_abnormal_birth_weight | 0.53288575 |
| 145 | MP0000427_abnormal_hair_cycle | 0.52375392 |
| 146 | MP0001177_atelectasis | 0.51892643 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.50760075 |
| 148 | MP0000627_abnormal_mammary_gland | 0.49723389 |
| 149 | MP0002972_abnormal_cardiac_muscle | 0.48108644 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.46769458 |
| 151 | MP0003283_abnormal_digestive_organ | 0.46249682 |
| 152 | MP0005501_abnormal_skin_physiology | 0.45899871 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.44504601 |
| 154 | MP0005076_abnormal_cell_differentiation | 0.43976968 |
| 155 | MP0005084_abnormal_gallbladder_morpholo | 0.43321035 |
| 156 | MP0009763_increased_sensitivity_to | 0.42088248 |
| 157 | MP0005058_abnormal_lysosome_morphology | 0.41857100 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.41419590 |
| 159 | MP0008004_abnormal_stomach_pH | 0.41136953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.77418563 |
| 2 | Oligomenorrhea (HP:0000876) | 8.94912389 |
| 3 | Increased mean platelet volume (HP:0011877) | 8.12962399 |
| 4 | Abnormal platelet volume (HP:0011876) | 7.95750902 |
| 5 | Menorrhagia (HP:0000132) | 7.48448359 |
| 6 | Petechiae (HP:0000967) | 7.45921480 |
| 7 | Acanthosis nigricans (HP:0000956) | 7.14237217 |
| 8 | Purpura (HP:0000979) | 6.84704900 |
| 9 | Hypertriglyceridemia (HP:0002155) | 6.21552049 |
| 10 | Epistaxis (HP:0000421) | 6.20325434 |
| 11 | Hyperglycinuria (HP:0003108) | 6.17214881 |
| 12 | Insulin-resistant diabetes mellitus (HP:0000831) | 6.06765188 |
| 13 | Gingival bleeding (HP:0000225) | 5.15093302 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.86962092 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.86962092 |
| 16 | Hypoglycemic coma (HP:0001325) | 4.69195931 |
| 17 | Long foot (HP:0001833) | 4.43563215 |
| 18 | Myoglobinuria (HP:0002913) | 4.34939606 |
| 19 | Ketoacidosis (HP:0001993) | 4.32261041 |
| 20 | Abnormal platelet function (HP:0011869) | 4.27865162 |
| 21 | Impaired platelet aggregation (HP:0003540) | 4.27865162 |
| 22 | Insulin resistance (HP:0000855) | 4.26925527 |
| 23 | Spontaneous hematomas (HP:0007420) | 4.17263090 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.03072821 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.88118504 |
| 26 | Growth hormone excess (HP:0000845) | 3.86735379 |
| 27 | Complement deficiency (HP:0004431) | 3.82607939 |
| 28 | Increased muscle lipid content (HP:0009058) | 3.81076315 |
| 29 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.76231214 |
| 30 | Abnormality of proline metabolism (HP:0010907) | 3.73936995 |
| 31 | Hydroxyprolinuria (HP:0003080) | 3.73936995 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.72864367 |
| 33 | Hepatosplenomegaly (HP:0001433) | 3.65522410 |
| 34 | Ketosis (HP:0001946) | 3.61162874 |
| 35 | Difficulty running (HP:0009046) | 3.60807441 |
| 36 | Bone cyst (HP:0012062) | 3.44170722 |
| 37 | Abnormality of macrophages (HP:0004311) | 3.38331365 |
| 38 | Pigmentary retinal degeneration (HP:0001146) | 3.24937177 |
| 39 | Rhabdomyolysis (HP:0003201) | 3.24220257 |
| 40 | Eczematoid dermatitis (HP:0000976) | 3.22074325 |
| 41 | Hyperglycemia (HP:0003074) | 3.16149044 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.15223149 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 3.15223149 |
| 44 | Polycythemia (HP:0001901) | 3.15070694 |
| 45 | Subcapsular cataract (HP:0000523) | 3.15032693 |
| 46 | Paralysis (HP:0003470) | 3.14543601 |
| 47 | Stomatitis (HP:0010280) | 3.08387481 |
| 48 | Decreased subcutaneous fat (HP:0001002) | 3.04498206 |
| 49 | Hyperglycinemia (HP:0002154) | 3.04090721 |
| 50 | Poikilocytosis (HP:0004447) | 3.02984360 |
| 51 | Large hands (HP:0001176) | 3.01664265 |
| 52 | Thyroid-stimulating hormone excess (HP:0002925) | 3.00809565 |
| 53 | Nausea (HP:0002018) | 2.99569433 |
| 54 | Multiple enchondromatosis (HP:0005701) | 2.97676722 |
| 55 | Pancreatitis (HP:0001733) | 2.94697612 |
| 56 | Increased connective tissue (HP:0009025) | 2.90085927 |
| 57 | Abnormality of the common coagulation pathway (HP:0010990) | 2.88330019 |
| 58 | Bruising susceptibility (HP:0000978) | 2.88133807 |
| 59 | Hyperthyroidism (HP:0000836) | 2.86516909 |
| 60 | Hypoalphalipoproteinemia (HP:0003233) | 2.86313000 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.84116052 |
| 62 | Epidermoid cyst (HP:0200040) | 2.83357975 |
| 63 | Prenatal maternal abnormality (HP:0002686) | 2.81490214 |
| 64 | Hyperpituitarism (HP:0010514) | 2.78417698 |
| 65 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.78159355 |
| 66 | Acanthocytosis (HP:0001927) | 2.75566077 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.73867056 |
| 68 | Conjunctival telangiectasia (HP:0000524) | 2.72302685 |
| 69 | Dyschromatopsia (HP:0007641) | 2.71420403 |
| 70 | Myocardial infarction (HP:0001658) | 2.69613296 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.67168697 |
| 72 | Hemorrhage of the eye (HP:0011885) | 2.64453873 |
| 73 | Abnormality of complement system (HP:0005339) | 2.62852409 |
| 74 | Abnormal pupillary function (HP:0007686) | 2.59509819 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 2.53482956 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51619363 |
| 77 | Obstructive lung disease (HP:0006536) | 2.51619363 |
| 78 | Hyperammonemia (HP:0001987) | 2.51036675 |
| 79 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.45643436 |
| 80 | Limb hypertonia (HP:0002509) | 2.45431603 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.43468094 |
| 82 | Episodic fever (HP:0001954) | 2.41860155 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.41815890 |
| 84 | Increased IgM level (HP:0003496) | 2.41530788 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 2.40804076 |
| 86 | Spinal rigidity (HP:0003306) | 2.39139236 |
| 87 | Abnormal hemoglobin (HP:0011902) | 2.37591036 |
| 88 | Toxemia of pregnancy (HP:0100603) | 2.35756274 |
| 89 | Polyphagia (HP:0002591) | 2.29958883 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.29904906 |
| 91 | Follicular hyperkeratosis (HP:0007502) | 2.29370609 |
| 92 | Ankle contracture (HP:0006466) | 2.28819354 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 2.28467146 |
| 94 | Hyperalaninemia (HP:0003348) | 2.28467146 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28467146 |
| 96 | Accelerated skeletal maturation (HP:0005616) | 2.27947123 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27323355 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.26952556 |
| 99 | Myositis (HP:0100614) | 2.26894075 |
| 100 | Joint hemorrhage (HP:0005261) | 2.24632356 |
| 101 | Broad metatarsal (HP:0001783) | 2.23822894 |
| 102 | Increased serum ferritin (HP:0003281) | 2.23592386 |
| 103 | Encephalitis (HP:0002383) | 2.23297764 |
| 104 | Hepatic necrosis (HP:0002605) | 2.21656477 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20179890 |
| 106 | Type 1 muscle fiber predominance (HP:0003803) | 2.18686766 |
| 107 | Brushfield spots (HP:0001088) | 2.18562007 |
| 108 | Tetraparesis (HP:0002273) | 2.17301519 |
| 109 | Symptomatic seizures (HP:0011145) | 2.15844205 |
| 110 | Skin nodule (HP:0200036) | 2.15638701 |
| 111 | Inflammation of the large intestine (HP:0002037) | 2.13289673 |
| 112 | Maternal diabetes (HP:0009800) | 2.11212725 |
| 113 | Lipoatrophy (HP:0100578) | 2.10900014 |
| 114 | Abnormality of lateral ventricle (HP:0030047) | 2.10848291 |
| 115 | Increased density of long bones (HP:0006392) | 2.10494646 |
| 116 | Polygenic inheritance (HP:0010982) | 2.06925619 |
| 117 | Joint swelling (HP:0001386) | 2.06257372 |
| 118 | Rectal prolapse (HP:0002035) | 2.04877399 |
| 119 | Ileus (HP:0002595) | 2.03799725 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03388169 |
| 121 | Amyloidosis (HP:0011034) | 2.02302440 |
| 122 | Hypercortisolism (HP:0001578) | 2.02030636 |
| 123 | Cerebral aneurysm (HP:0004944) | 2.01613225 |
| 124 | Dysostosis multiplex (HP:0000943) | 2.00891017 |
| 125 | Glucose intolerance (HP:0000833) | 2.00421712 |
| 126 | Prominent supraorbital ridges (HP:0000336) | 1.99235615 |
| 127 | Clitoromegaly (HP:0000057) | 1.99021500 |
| 128 | Orchitis (HP:0100796) | 1.98159550 |
| 129 | Enlarged penis (HP:0000040) | 1.97402199 |
| 130 | Gastrointestinal inflammation (HP:0004386) | 1.97290222 |
| 131 | Polar cataract (HP:0010696) | 1.92430994 |
| 132 | Facial diplegia (HP:0001349) | 1.89589912 |
| 133 | Turricephaly (HP:0000262) | 1.89458762 |
| 134 | Hyperuricemia (HP:0002149) | 1.88969756 |
| 135 | Increased purine levels (HP:0004368) | 1.88969756 |
| 136 | Hyperlipoproteinemia (HP:0010980) | 1.88646690 |
| 137 | Muscle fiber splitting (HP:0003555) | 1.88437299 |
| 138 | Acute hepatic failure (HP:0006554) | 1.88043122 |
| 139 | Arterial thrombosis (HP:0004420) | 1.87236980 |
| 140 | Colitis (HP:0002583) | 1.87138802 |
| 141 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.86781857 |
| 142 | Back pain (HP:0003418) | 1.85775702 |
| 143 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85421999 |
| 144 | Proximal amyotrophy (HP:0007126) | 1.81364618 |
| 145 | Chest pain (HP:0100749) | 1.79231914 |
| 146 | Hypophosphatemic rickets (HP:0004912) | 1.75975546 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.75788432 |
| 148 | Conjunctival hamartoma (HP:0100780) | 1.75619037 |
| 149 | Abnormal eating behavior (HP:0100738) | 1.75566645 |
| 150 | Renal cortical cysts (HP:0000803) | 1.75475876 |
| 151 | Hypercholesterolemia (HP:0003124) | 1.75408870 |
| 152 | Granulocytopenia (HP:0001913) | 1.75036332 |
| 153 | Vertigo (HP:0002321) | 1.74665198 |
| 154 | Lethargy (HP:0001254) | 1.73366926 |
| 155 | Goiter (HP:0000853) | 1.73256254 |
| 156 | Hyperkalemia (HP:0002153) | 1.72850847 |
| 157 | Optic neuritis (HP:0100653) | 1.72368710 |
| 158 | Retrobulbar optic neuritis (HP:0100654) | 1.72368710 |
| 159 | Recurrent fungal infections (HP:0002841) | 1.71064334 |
| 160 | Muscle stiffness (HP:0003552) | 1.70598380 |
| 161 | Glomerulopathy (HP:0100820) | 1.69888118 |
| 162 | Easy fatigability (HP:0003388) | 1.68885181 |
| 163 | Keratoconjunctivitis sicca (HP:0001097) | 1.67855888 |
| 164 | Gastrointestinal infarctions (HP:0005244) | 1.67837812 |
| 165 | Xanthomatosis (HP:0000991) | 1.67705217 |
| 166 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67265788 |
| 167 | Leukocytosis (HP:0001974) | 1.66174326 |
| 168 | Hypochromic microcytic anemia (HP:0004840) | 1.63251926 |
| 169 | Tinnitus (HP:0000360) | 1.61805822 |
| 170 | Microcytic anemia (HP:0001935) | 1.61776682 |
| 171 | Vasculitis (HP:0002633) | 1.60829793 |
| 172 | Gastrointestinal dysmotility (HP:0002579) | 1.60614207 |
| 173 | Dysautonomia (HP:0002459) | 1.59564192 |
| 174 | Autoimmune hemolytic anemia (HP:0001890) | 1.59158109 |
| 175 | Gingivitis (HP:0000230) | 1.58976900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 7.00758457 |
| 2 | RIPK4 | 6.26142278 |
| 3 | CAMK1G | 4.93791049 |
| 4 | TRIB3 | 4.73042278 |
| 5 | BCKDK | 4.64249603 |
| 6 | SIK1 | 4.51185095 |
| 7 | INSRR | 3.07134299 |
| 8 | ERN1 | 2.81544007 |
| 9 | PDK4 | 2.80042834 |
| 10 | PDK3 | 2.80042834 |
| 11 | BTK | 2.77058472 |
| 12 | RIPK1 | 2.62857979 |
| 13 | MST4 | 2.31773132 |
| 14 | MST1R | 2.27395273 |
| 15 | LMTK2 | 2.27167008 |
| 16 | FRK | 2.22214388 |
| 17 | FES | 2.18857288 |
| 18 | BLK | 2.15602964 |
| 19 | SYK | 2.03291327 |
| 20 | GRK6 | 2.00449953 |
| 21 | PRKAA2 | 2.00185302 |
| 22 | GRK5 | 1.88811870 |
| 23 | TNK2 | 1.84371157 |
| 24 | EIF2AK1 | 1.83199264 |
| 25 | CDK9 | 1.79539949 |
| 26 | CSF1R | 1.68051025 |
| 27 | TAOK3 | 1.63921553 |
| 28 | PIK3CG | 1.63332600 |
| 29 | PDK2 | 1.60861236 |
| 30 | HCK | 1.57456192 |
| 31 | PDGFRA | 1.34781376 |
| 32 | LATS1 | 1.33925067 |
| 33 | FGR | 1.33490129 |
| 34 | MAP2K1 | 1.32304774 |
| 35 | LYN | 1.29729393 |
| 36 | FGFR3 | 1.28075827 |
| 37 | BMPR2 | 1.25846323 |
| 38 | PRKD3 | 1.20724951 |
| 39 | STK16 | 1.20357016 |
| 40 | MAPK12 | 1.18688586 |
| 41 | MAP4K1 | 1.14100021 |
| 42 | FGFR2 | 1.13894737 |
| 43 | EPHB2 | 1.13333944 |
| 44 | PIK3CA | 1.12872653 |
| 45 | MET | 1.09338497 |
| 46 | PRKAA1 | 1.08029401 |
| 47 | PIM2 | 1.07961957 |
| 48 | EPHB1 | 1.04704433 |
| 49 | MAP3K3 | 1.02955223 |
| 50 | IRAK3 | 1.01735653 |
| 51 | IRAK4 | 1.01435682 |
| 52 | PRPF4B | 0.99020423 |
| 53 | MATK | 0.97817568 |
| 54 | ADRBK1 | 0.97736856 |
| 55 | MAP3K6 | 0.94848730 |
| 56 | IKBKB | 0.94621122 |
| 57 | KIT | 0.93582858 |
| 58 | TYK2 | 0.93052430 |
| 59 | MAP3K11 | 0.92847223 |
| 60 | CDK6 | 0.92327890 |
| 61 | PAK1 | 0.90667563 |
| 62 | FLT3 | 0.88719859 |
| 63 | ITK | 0.84521688 |
| 64 | MAP2K3 | 0.82051693 |
| 65 | ARAF | 0.81469309 |
| 66 | JAK1 | 0.79182472 |
| 67 | TXK | 0.78042699 |
| 68 | YES1 | 0.77886011 |
| 69 | DAPK3 | 0.77653427 |
| 70 | DDR2 | 0.77451765 |
| 71 | MARK3 | 0.77386576 |
| 72 | PDGFRB | 0.75425481 |
| 73 | CAMKK2 | 0.75351199 |
| 74 | PKN2 | 0.74394346 |
| 75 | LCK | 0.73796889 |
| 76 | MAPK4 | 0.73212230 |
| 77 | FER | 0.72423373 |
| 78 | TGFBR2 | 0.69985907 |
| 79 | TAOK2 | 0.69331208 |
| 80 | SIK3 | 0.68740232 |
| 81 | MAPKAPK3 | 0.68499706 |
| 82 | PDPK1 | 0.67900963 |
| 83 | JAK2 | 0.67601006 |
| 84 | TIE1 | 0.67207786 |
| 85 | PRKCH | 0.67001448 |
| 86 | MAP3K5 | 0.65738205 |
| 87 | MAP3K1 | 0.65710004 |
| 88 | CAMK1 | 0.63477474 |
| 89 | IGF1R | 0.62245882 |
| 90 | JAK3 | 0.61950398 |
| 91 | MAPK11 | 0.61159851 |
| 92 | MAP3K2 | 0.59365849 |
| 93 | ABL2 | 0.58143479 |
| 94 | FGFR4 | 0.56812029 |
| 95 | PRKACG | 0.55812086 |
| 96 | PKN1 | 0.55127318 |
| 97 | GSK3A | 0.53079240 |
| 98 | DAPK2 | 0.50558392 |
| 99 | RET | 0.50195547 |
| 100 | MTOR | 0.50012246 |
| 101 | TBK1 | 0.49962976 |
| 102 | PDK1 | 0.46857893 |
| 103 | PRKD2 | 0.46250400 |
| 104 | PHKG1 | 0.45128916 |
| 105 | PHKG2 | 0.45128916 |
| 106 | MAPK15 | 0.44332819 |
| 107 | IRAK1 | 0.44105031 |
| 108 | LRRK2 | 0.43790367 |
| 109 | NEK9 | 0.43522553 |
| 110 | NLK | 0.43236374 |
| 111 | LATS2 | 0.42678979 |
| 112 | FYN | 0.41958878 |
| 113 | MYLK | 0.41834264 |
| 114 | PRKD1 | 0.41616367 |
| 115 | EIF2AK2 | 0.41486600 |
| 116 | KSR2 | 0.41346223 |
| 117 | RAF1 | 0.40410044 |
| 118 | PRKG1 | 0.40334866 |
| 119 | RPS6KB1 | 0.38980919 |
| 120 | PIM1 | 0.36969869 |
| 121 | PAK2 | 0.35637123 |
| 122 | TRPM7 | 0.35618463 |
| 123 | ADRBK2 | 0.34919935 |
| 124 | PINK1 | 0.34576827 |
| 125 | TAOK1 | 0.33886400 |
| 126 | FGFR1 | 0.32876402 |
| 127 | CDK4 | 0.32807045 |
| 128 | INSR | 0.32143274 |
| 129 | MARK2 | 0.31468831 |
| 130 | HIPK2 | 0.30869419 |
| 131 | EPHA3 | 0.30601422 |
| 132 | PRKG2 | 0.30367352 |
| 133 | IRAK2 | 0.28451684 |
| 134 | STK3 | 0.28195298 |
| 135 | STK38L | 0.27552475 |
| 136 | PTK6 | 0.27317860 |
| 137 | ILK | 0.26243405 |
| 138 | AKT1 | 0.22629876 |
| 139 | CSK | 0.21050712 |
| 140 | SRC | 0.20630443 |
| 141 | TEC | 0.19908024 |
| 142 | PASK | 0.19433613 |
| 143 | MAP2K2 | 0.18738928 |
| 144 | PTK2B | 0.17917885 |
| 145 | BMX | 0.17738129 |
| 146 | MAPK3 | 0.14975258 |
| 147 | ABL1 | 0.13725695 |
| 148 | PRKCZ | 0.13084023 |
| 149 | PRKACA | 0.12829202 |
| 150 | PRKCE | 0.11927119 |
| 151 | ZAP70 | 0.11859948 |
| 152 | MAP2K6 | 0.10290158 |
| 153 | STK38 | 0.09614936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.22549072 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.78684539 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.22480144 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.09916933 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.91162542 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.78628953 |
| 7 | Platelet activation_Homo sapiens_hsa04611 | 3.71528561 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.48605018 |
| 9 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.28362708 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.84066552 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.51190118 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.41791771 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.24591837 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.09806798 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.99961824 |
| 16 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.96761275 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.95851937 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82296966 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76900469 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.74282306 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.69676323 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.63421641 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61852557 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.57514815 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52595108 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.49610181 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49007428 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48602772 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44801593 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32053121 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.31567830 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.19053347 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18760742 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18110194 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12842830 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11203292 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04351837 |
| 38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02397533 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98877490 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96095146 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95206498 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93955008 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93618023 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91732861 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90869276 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.90100015 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89078987 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88960721 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87271870 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85302435 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 0.85182122 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83295233 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83207905 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83023546 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.81457696 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80491045 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79816887 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 0.79546178 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77879009 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.77375976 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74800869 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73126007 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72941446 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.70904477 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69114096 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65513355 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63998873 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63659120 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62188645 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61948069 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61551540 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61516663 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60833403 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60725929 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.60037719 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59725729 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59440447 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58859419 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57908175 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56946640 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54940565 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53384394 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52155138 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50988692 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49554315 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49459273 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49048091 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.48133022 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.48075899 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47294266 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.46876652 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46820614 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45498791 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44753800 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44461065 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44160571 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41776781 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41192684 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40683661 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.37128931 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36774347 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36611535 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35671756 |
| 104 | Allograft rejection_Homo sapiens_hsa05330 | 0.35232468 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34988084 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.34297605 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32799270 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.32745314 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.31929125 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31812298 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31667116 |
| 112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30432948 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29939439 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.29878190 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.28769362 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.28609226 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28141026 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27309689 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27226175 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26780891 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.25034861 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24741360 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.24723804 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24529156 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23726781 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23628627 |
| 127 | Focal adhesion_Homo sapiens_hsa04510 | 0.23068542 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21208615 |
| 129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.20360334 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.20265151 |
| 131 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.19060240 |
| 132 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.18839402 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17817737 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.12620817 |
| 135 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.10586842 |
| 136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10144055 |
| 137 | Protein export_Homo sapiens_hsa03060 | 0.09048363 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.07874245 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.07724595 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07544899 |
| 141 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.07494421 |
| 142 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06941752 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06588987 |
| 144 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.06518739 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.05906935 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.05695138 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05183711 |
| 148 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.04665291 |
| 149 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.03195681 |
| 150 | Retinol metabolism_Homo sapiens_hsa00830 | 0.02724837 |
| 151 | Amoebiasis_Homo sapiens_hsa05146 | 0.02537603 |
| 152 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.01979595 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | 0.01079816 |
| 154 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.00596476 |

